The Drosophila serum response factor (DSRF) is expressed in the precursors of the terminal tracheal cells and in the future intervein territories of the third instar wing imaginal disc. Dissection of the DSRF regulatory region reveals that a single enhancer element, which is under the control of the ®broblast growth factor (FGF)-receptor signalling pathway, is suf®cient to induce DSRF expression in the terminal tracheal cells. In contrast, two separate enhancers direct expression in distinct intervein sectors of the wing imaginal disc. One element is active in the central intervein sector and is induced by the Hedgehog signalling pathway. The other element is under the control of Decapentaplegic and is active in two separate territories, which roughly correspond to the intervein sectors¯anking the central sector. Hence, each of the three characterized enhancers constitutes a molecular link between a speci®c territory induced by a morphogen signal and the localized expression of a gene required for the ®nal differentiation of this territory. q
Introduction
During the development of multicellular organisms, cascades of regulatory genes establish discrete territories within undifferentiated cells, resulting in the local activation of speci®c target genes. Often, these intermediate target genes induce the differentiation of cells into functional tissues by regulating the expression of selective structural genes. The Drosophila serum response factor (DSRF) is encoded by such an intermediate gene required for terminal tracheal cells and wing intervein tissue development as it is expressed in the corresponding precursor cells and is necessary for their appropriate differentiation (Affolter et al., 1994; Guillemin et al., 1996; Montagne et al., 1996) . DSRF belongs to a family of regulatory proteins characterized by a highly conserved DNA binding/dimerization domain termed the MADS box (Shore and Sharrocks, 1995) , and thus presumably acts by regulating gene expression.
In cell culture experiments, mammalian serum response factor (SRF) has been shown to regulate transcription by forming a DNA-bound complex implicated in the integration of a number of cytoskeletal rearrangements and signalling cascades in response to growth factor stimulation (Treisman, 1996; Cahill et al., 1996; Sotiropoulos et al., 1999) . During development, SRF expression levels appear to be modulated. In Xenopus laevis, SRF-related proteins are detected in myotones of the early embryo (Chambers et al., 1992) . Similarly, zebra®sh SRF is transiently observed at high level in skeletal muscle cells during their differentiation (Vogel and Gerster, 1999) and avian SRF is expressed in the muscle cell lineages, where it is required for a-actin gene transcription (Croissant et al., 1996) . In mouse embryos, SRF is ®rst ubiquitously present, and later strongly detected in the myotones and in the future cardia (Belaguli et al., 1997; Arsenian et al., 1998) . Hence, localized activation of SRF target genes may depend on restricted SRF expression in speci®c tissues and/or on the selective activation of signalling cascades modulating the transcriptional activity of SRF.
In the Drosophila embryo, DSRF is provided maternally but decays early (Affolter et al., 1994) . Later in embryogenesis, DSRF is strongly detected in all terminal cells at the periphery of the tracheal system prior to the differentiation of long cytoplasmic extensions, called terminal branches, which provide oxygen to the target tissues (Affolter et al., 1994; Guillemin et al., 1996) . A P-element insertion, which results in a strong loss-of-function mutation in DSRF, completely abolishes terminal branch formation . DSRF expression in these terminal cells is induced by FGF signalling and requires the FGF-like ligand Branchless (BNL, Lee et al., 1996; Sutherland et al., 1996) and the FGF receptor Breathless (BTL, Kla Èmbt et al., 1992) . DSRF expression in terminal tracheal cells is then maintained throughout the larval stages of development .
DSRF is also expressed in the wing imaginal discs of third instar larvae, in the cells that later give rise to the highly specialized intervein tissue of the wing. Molecular and genetic analysis revealed that the P-element-induced DSRF mutation is allelic to previously identi®ed blistered (bs) mutations which fail to differentiate intervein tissue (Bridges and Morgan, 1915; Fristrom et al., 1994; Montagne et al., 1996) . Thus the gene is hereafter referred to as bs/DSRF.
The vein±intervein network of the adult wing is organized into ®ve intervein sectors demarcated by the longitudinal veins (intervein sectors A to E and veins L2 to L5, according to the nomenclature of Garcia-Bellido et al., 1994) . The Hedgehog (Hh) signalling pathway organizes this vein±intervein network by (i) a direct morphogen effect in patterning the central intervein sector C and positioning the longitudinal vein L3 (Mullor et al., 1997; Strigini and Cohen, 1997) and (ii) inducing the expression of the Decapentaplegic (Dpp) morphogen which triggers the expression of spalt, spaltrelated and opto-motor-blind (de Celis et al., 1996; Lecuit et al., 1996; Nellen et al., 1996) . These target genes, in turn, position the other intervein domains and longitudinal veins (Sturtevant et al., 1997; Biehs et al., 1998) . However, none of the identi®ed morphogen target genes is speci®cally expressed in either all future vein or intervein territories. Rather, they function to set the boundaries between the different sectors. Nevertheless, these intricate morphogen cascades eventually trigger the expression of vein speci®c (i.e. veinlet/ rhomboid (ve/rho); Sturtevant et al., 1993) and intervein speci®c (i.e. bs/DSRF) genes. Thus far, bs/DSRF is the only gene whose restricted expression to the presumptive interveins is maintained from third instar larvae until the adult wing of the emerging¯y (Montagne et al., 1996) .
To investigate the molecular mechanisms that drive the expression of bs/DSRF, we searched for regulatory sequences of the locus. Here, we report the identi®cation of individual enhancer elements that direct bs/DSRF expression in the terminal tracheal cells and the future intervein cells. We demonstrate that their activity is regulated by distinct morphogen signalling pathways.
Results

Strategy for identi®cation of cis-regulatory elements directing the expression of bs/DSRF
To identify the enhancers that control the temporal and spatial expression of the bs/DSRF gene during development, various potential regulatory elements were fused to a minimal promoter driving expression of either a cytoplasmic (HZ) or a nuclear (pCb ) lacZ reporter gene. The bs/DSRF transcription unit lies at a distance of 9 kb from the slbo locus in position 60B (Montell et al., 1992; Affolter et al., 1994) (Fig. 1) . The intervening DNA segment was initially subdivided into three fragments, which were tested for enhancer activity. As regulatory elements may also be present within introns, the DNA fragment containing the proximal promoter and the ®rst intron of the bs/DSRF gene was also analyzed. Upon germ line transformation, the expression pattern of the transgenes were analyzed during embryonic and larval development in several independent¯y lines. For those fragments that were found to drive expression in relevant tissues, a deletion analysis was undertaken to delimit more precisely the regulatory sequences ( Fig. 1 and data not shown). Our analysis led to the identi®cation of three distinct enhancer elements. A 500-bp fragment, which lies approximately 2.5 kb upstream of the transcription start site, directs expression of the lacZ reporter gene in all terminal tracheal cells ( Fig. 1 ; pCb 0.5). Two distinct enhancer elements (pCb 1.8 and HZ 4.4) were found to drive expression in different territories of the developing wing imaginal disc (Fig. 1) . In the following, we describe each of the three enhancers and how they are regulated during development.
2.2. The trachea enhancer of the bs/DSRF gene is regulated by the FGF signaling pathway By stage 14 of embryogenesis, bs/DSRF transcription is activated to high levels in all terminal tracheal cells (Affolter et al., 1994; Guillemin et al., 1996) (Fig. 2C) . In embryos transgenic for the HZ 4.4 construct, a similar b -galactosidase expression pattern was detected ( Fig. 2A and data not shown). Since the b -galactosidase produced in the HZ transformants is localized in the cytoplasm, the ®ne cytoplasmic extensions differentiated by terminal tracheal cells were readily visible, supporting the identi®cation of the cells expressing the b -galactosidase as terminal tracheal cells. Further deletion analysis using a nuclear b -galactosidase reporter led to the identi®cation of a 500-bp DNA fragment suf®cient to drive this expression pattern (Fig. 2, compare B with A). Double staining with an antibody detecting an antigen present in the tracheal lumen (see Section 4) con®rmed that these bgalactosidase expressing cells indeed correspond to the terminal tracheal cells (Fig. 2B) . We termed this 500-bp fragment, which resides approximately 2.5 kb upstream of the transcriptional start site, the`terminal cell enhancer' (TCE). Since bs/DSRF encodes a transcriptional regulator whose vertebrate homologues are known to be autoregulated (Belaguli et al., 1997) , we investigated whether the spatial activation of the TCE depends on the activity of the endogenous Bs/DSRF protein. In agreement with previous observations showing that bs/DSRF is not autoregulated , the TCE was still active in embryos homozygous for a de®ciency that deletes the bs/DSRF gene (Fig. 2, compare D with C) . To further demonstrate that the TCE represents thè bona ®de' tracheal enhancer of the bs/DSRF gene, we analyzed its expression in pointed (pnt) mutant embryos which fail to develop tertiary tracheal branches and to activate bs/DSRF transcription . Indeed, the TCE was not activated in pnt mutant embryos, faithfully re¯ecting the regulation of the endogenous bs/DSRF gene (Fig. 2E) .
Previous reports showed that bs/DSRF expression is controlled by BNL (FGF) signalling Hacohen et al., 1998) . When FGF receptor signalling is activated throughout the embryo (by ubiquitous expression of either the BNL ligand or an activated form of the FGF receptor BTL), many more tracheal cells develop extensive terminal branches and activate transcription of bs/DSRF (Lee et al., 1996; Sutherland et al., 1996) . The TCE element mimicked expression of the bs/DSRF gene, as it was activated in many more tracheal cells upon the activation of the FGF signalling pathway in the entire tracheal system (Fig. 2F) . Therefore, the TCE appears to integrate the temporal and spatial cues which drive the expression of the bs/DSRF gene in the terminal tracheal cells.
Expression of bs/DSRF in intervein cells of the wing imaginal disc is controlled by two separate enhancer elements
From third instar larvae until eclosion, bs/DSRF is expressed in all presumptive intervein cells of the future wing to promote intervein tissue formation (Montagne et al., 1996) (Fig. 3A,B) . Although bs/DSRF is the earliest gene identi®ed to date that marks the future intervein territories, little is known about the regulation of its expression. Much work has focused on the spatially restricted formation of vein territories in the wing imaginal disc. One of the genes whose transcription ®rst marks the presumptive vein territories during disc development is ve/rho (Sturtevant et al., 1993) . Ve/Rho encodes a putative transmembrane protein and acts as a positive regulator of the Drosophila EGF signalling pathway (Sturtevant et al., 1993) . The expression of ve/rho is controlled by the longrange organizers of the wing ®eld (Sturtevant and Bier, 1995; Sturtevant et al., 1997; Biehs et al., 1998; Lunde et al., 1998) . Therefore, a simple mechanism to delimit bs/ DSRF expression to the intervein territory in the developing Fig. 1 . Schematic map of the putative regulatory sequences of the bs/DSRF gene. The slbo and the two ®rst exons of the bs/DSRF transcription units are represented; the arrows indicate the direction of mRNA polymerization. The P-element insertion site is indicated above the DNA. The various DNA fragments, which were fused to a lacZ reporter gene and used to establish transgenic¯y lines in the course of this study, are represented below. The four restriction fragments generated by EcoRI (E) digest were derived from a lambda phage . Further deletions utilized other restriction enzymes (H, HindIII; P, PstI; X, XhoI). pCb is the cloning vector encoding a nuclear b-galactosidase, whereas HZ corresponds to pHZ50pL and encodes a cytoplasmic bgalactosidase. The HZ4.4 element also contains the enhancer activating slbo transcription in border cells in the developing egg chamber during oogenesis (Rùrth et al., 1998; N. Grieder, personal communication) . The Vg/Sd binding sites are localized in the insert of pCb 0.7 (Halder et al., 1998). wing would consist of the regional repression of a wingblade speci®c enhancer in the developing vein territories. However, we found that two different enhancer elements were active in the developing wing imaginal disc and directed b -galactosidase expression in non-overlapping adjacent territories (Fig. 3) . A promoter-proximal DNA element was found to induce the reporter gene in the centre of the wing blade (Fig. 3C ). Since this enhancer is active along the compartment boundary (see below) we refer to it as the boundary enhancer. A second, more distal element was found to be active in two widely spaced domains, residing in the middle of either the anterior or the posterior compartment (Fig. 3D ). This expression domain appears symmetrical around the intervein C region and is presumably required for bs/DSRF expression in intervein B and D territories. Double antibody staining is necessary to address this issue, but unfortunately, expression levels directed by this enhancer and shorter derivatives thereof give expression too low to be detected by antibody staining. This enhancer element is very likely to integrate Dpp signalling, as it is active at an equal distance on both sides of the Dpp source. To investigate this possibility, high level of Dpp was induced in the entire wing pouch using the UAS-GAL4 system (Brand and Perrimon, 1993) . Indeed, expression of the b -galactosidase reporter driven by this enhancer element was disrupted and suppressed in the presumptive intervein B and D regions (Fig. 3F) . Further analysis of this element may help to understand how different levels of the Dpp morphogen control the formation of symmetrically positioned domains on either side of the A/P compartment boundary.
The boundary enhancer is controlled by Hedgehog signalling
The intervein C region of the adult wing is subdivided by the invisible A/P compartment boundary into a large and a small ®eld belonging to the anterior and the posterior compartments respectively . In the wing of a newly emerged¯y, the expression of bs/ DSRF is observed in the entire intervein C region, in both its large anterior and much narrower posterior part (Montagne et al., 1996) . To delimit the exact expression boundary during imaginal development, we ®rst analyzed bs/DSRF expression with respect to the A/P compartment boundary. The A/P boundary was visualized using a hh-lacZ reporter construct, which is expressed in the posterior compartment. In third instar wing disc, bs/DSRF expression in the prospective intervein C domain abutted the hh±lacZ expression pattern (Fig. 4A,B) . In contrast to most of the bs/DSRF expression boundaries along the vein territories, which are not well delimited, the transition between bs/DSRF expressing and non-expressing cells along the A/P boundary is very sharp. Since bs/DSRF expression aligns with the A/P boundary in the third instar wing disc but is observed in the posterior compartment in the wing of a newly emerged¯y, the expression domain of bs/DSRF must expand during pupation.
Co-localization analysis of Bs/DSRF and b-galactosidase directed by the boundary enhancer revealed that the boundary enhancer is active in the prospective intervein C region (Fig. 4C,D) . Hh plays a morphogenic role in organizing the intervein C sector (Mullor et al., 1997; Strigini and Cohen, 1997) . Cubitus interruptus (Ci) is essential for transducing the Hh signal by regulating the transcription of target genes. In the absence of Hh signalling, Ci is processed to form a nuclear repressor for certain target genes. Activation of the Hh signalling pathway decreases the processing of the repressor form and increases the level of unprocessed Ci which in turn activates target genes (Chen et al., 1999; Me Âthot and Basler, 1999) .
To determine how the boundary enhancer is regulated, we induced high levels of either Hh or Dpp in the entire wing pouch of the third instar wing imaginal disc. Consistent with a positive input of Hh signalling, the boundary enhancer was activated throughout the anterior compartment upon overexpression of Hh (Fig. 3E) . In contrast, Dpp overexpression did not expand the b -galactosidase expression driven by the boundary enhancer (data not shown). To con®rm that the activity of the boundary enhancer was triggered through Hh signalling via Ci and to test whether the response is cell-autonomous, we ectopically induced high levels of Ci in small clones of cells. Such clones autonomously activated the boundary enhancer in the posterior compartment (Fig. 4E,F) . In contrast, Fig. 3 . Identi®cation of distinct enhancers responsible for expression of bs/ DSRF restricted to the intervein territories in the third instar wing disc. (A) Schematic drawing of a wing disc showing the territories which de®ne the future positions of the intervein domains. The`pro-intervein' domains are referred to as A to E and each of them is split in two symmetrical domains by the dorsal±ventral compartment boundary. (B±F) Detection of b-galactosidase activity by histochemical staining of late third instar wing discs. (B) larvae heterozygous for the P-element insertion in bs/DSRF. (C) transgenic larvae carrying the 1.8-kb DNA element (see Fig. 1 , pCb 1.8). (D) transgenic larvae carrying the 4.4-kb DNA element (see Fig.  1 , HZ 4.4; HZ 2.7 shows a similar expression pattern). (E) transgenic larvae carrying the 1.8-kb DNA element and misexpressing Hh in the entire wing pouch using a UAS-hh transgene and the MS1096 Gal4 driver. (F) transgenic larvae carrying the 4.4-kb DNA element and misexpressing Dpp in the entire wing pouch using a UAS-dpp transgene and the MS1096 Gal4 driver. All discs are oriented anterior to the left and dorsal to the top. the boundary enhancer was not activated in clones in the anterior compartment, which do not receive the Hh signal (Fig. 4E,F) . In addition, activation of the enhancer was restricted to the developing wing ®eld (Fig. 4E,F) . To address whether the enhancer activation requires Hh signalling, we analyzed its activity in clones mutant for the Hh receptor Smoothened (Smo) . The boundary enhancer was not activated in clones lacking smo (Fig. 5) , indicating a cell-autonomous requirement for Hh signalling. In summary, our results demonstrate that in third instar wing imaginal discs, the boundary enhancer is activated by Hh signalling in anterior cells adjacent to the posterior compartment through its receptor Smo and its effector Ci.
Discussion
During embryonic and larval development bs/DSRF is expressed in the terminal tracheal cells (Affolter et al., 1994; Guillemin et al., 1996) and from mid±third instar larvae until eclosion of the adult¯y, bs/DSRF is expressed in the future intervein tissue of the wing imaginal disc (Montagne et al., 1996) . We have identi®ed the cis-regulatory elements and the signalling cascades involved in this transcriptional regulation.
An enhancer activated in terminal tracheal cells is regulated by FGF (BNL) signalling
We have isolated a 500 bp enhancer element (TCE) whose activity reproduces the bs/DSRF expression pattern in the terminal tracheal cells, with respect to its temporal, spatial and regulatory cues. The TCE is the ®rst enhancer identi®ed in Drosophila that responds to FGF signalling. It has been reported that the FGF signalling cascade activates the MAP kinase pathway (Reichman-Fried et al., 1994; Kouhara et al., 1997) and that the Ets-domain containing protein Pnt is a target for the ERK-MAP kinase (O'Neill et al., 1994) . Therefore, the expression of the TCE is likely to be controlled by FGF signalling which, through the ERK-MAP kinase pathway, activates a Pnt±DNA-bound complex in conjunction with other factors . Further dissection of the enhancer and the identi®cation of the individual DNA sites and the relevant transcription factors should help to elucidate how FGF triggers speci®c nuclear responses. Interestingly, during early mesoderm induction in Xenopus laevis, an Ets±SRF complex has been implicated in transducing FGF signalling (Panitz et al., 1998) . Therefore, bs/DSRF might not only be a target gene whose transcription is activated in response to FGF signalling, but also encodes a protein that assembles into a complex to integrate the FGF signal. However, the TCE does not require DSRF itself for signal induction as it is still active in a bs/DSRF loss-of-function mutant. Nevertheless, and as already suggested , other putative target genes induced via FGF signalling in the terminal tracheal cells could require the activation of an Ets-DSRF-DNA complex.
Is bs/DSRF a marker for`pro-intervein' territories?
Two classes of genes involved in the late differentiation of the wing have been characterized previously: veinpromoting genes (e.g. ve/rho, vein) and vein-suppressing genes (e.g. bs, net, plexus) (Diaz-Benjumea and GarciaBellido, 1990). However, we previously proposed that bs/ DSRF should be considered as an`intervein-promoting gene' since its expression in wing cells is required to determine intervein fate (Montagne et al., 1996) . The expression of bs/DSRF is negatively regulated in vein territories by the EGF signalling pathway (Roch et al., 1998) , whereas ve/rho expression is restricted to the future veins in the wing pouch and this expression is indirectly controlled by the long range organizers of the wing ®eld (Sturtevant et al., 1997; Lunde et al., 1998) . Therefore, the simplest mechanism for establishment of the vein-intervein network would be to spatially activate vein-speci®c genes, which, through their activity, would repress a wing-blade speci®c enhancer in the developing vein territories. Surprisingly, our promoter analysis reveals that bs/DSRF expression in different presumptive intervein territories depends on distinct enhancers, which are controlled by different morphogen events. Congruent with this observation, Biehs et al. (1998) propose that the vein±intervein network has to be considered on a stripe-by-stripe basis. Since the EGF signalling pathway represses bs/DSRF expression in the third instar wing disc (Roch et al., 1998) , the bs/DSRF promoter could also contain DNA elements negatively regulated by EGF signalling. In summary, the expression of bs/DSRF in the future intervein cells is triggered by the integration of several signalling events, probably through distinct regulatory elements. Roch et al. (1998) propose that once the vein and intervein domains have been demarcated independently, gene interactions may occur at vein±intervein boundaries to maintain and re®ne their respective domains. During metamorphosis, veins differentiate within the broader provein territories (de Celis and Garcia-Bellido, 1994; de Celis, 1997) . Here we have shown that the bs/DSRF expression domain within the future intervein sector C abuts the A/P boundary, although at the end of metamorphosis, this expression expands into adjacent posterior cells (Montagne et al., 1996) . Thus, since the provein territory L4 is posterior and abuts the A/P boundary , Bs/ DSRF in the third instar wing disc is excluded from this provein territory at the A/P boundary. It will be of great interest to determine whether Bs/DSRF is excluded from the other provein domains of the third instar wing disc. In this case, bs/DSRF would have to be considered as an early marker for`pro-intervein' territories ( Fig. 3A) and its expression would progressively expand during metamorphosis to the ®nal intervein domains of the adult wing.
Hedgehog signaling activates bs/DSRF expression in intervein C
We have identi®ed an enhancer (the boundary enhancer) that is activated by Hh signalling in the cells anterior to the A/P compartment boundary. In agreement with previous reports demonstrating a direct morphogenic role of Hh in the central region of the wing (Mullor et al., 1997; Strigini and Cohen, 1997) , this might indicate that the Hh signalling is required to trigger intervein differentiation through DSRF expression in the intervein C domain. However, in contradiction to the activity of the boundary enhancer, bs/DSRF is expressed in smo mutant clones analyzed during pupal development (Blair and Ralston, 1997) . Noteworthy, the clones we generated were analyzed during third instar, whereas bs/DSRF expression was detected later, 24±36 h after puparium formation. At this time, gene interactions between vein-and intervein-speci®c genes might be suf®-cient to maintain their respective, mutually exclusive expression domains (Roch et al., 1998) . Thus, Hh would be required only for the early setting of bs/DSRF expression as a result of patterning the intervein sector C. Indeed, bgalactosidase expression directed by the boundary enhancer was not detected in the wing of newly emerged¯ies (J.M., unpublished results). This indicates that in the presumptive intervein sector C, the early setting of bs/DSRF is controlled through the boundary enhancer, whereas the later expression might recruit another cis-regulatory element. The fact that the expression of bs/DSRF is observed in the posterior compartment of pupal wings, whereas the boundary enhancer is restricted to the anterior compartment in third instar discs, further supports this idea.
Recently, it has been shown that the boundary enhancer we characterized is directly regulated by Vestigial (Vg) and Scalloped (Sd) which form a complex on a 120-bp DNA sub-element (Halder et al., 1998) . The wing-speci®c Vg±Sd complex restricts the activation of the boundary enhancer to the future wing, consistent with the ®nding that Ci can only activate it in the pouch region. Hence, the boundary enhancer integrates positional cues from the Vg±Sd transcriptional complex (Halder et al., 1998) and the Hh signal (this study). More recently, the gene knot/collier (kn), which encodes a putative DNA-binding protein acting downstream of the Hh signalling pathway, was found to be required for the expression of bs/DSRF in the intervein sector C (Vervoort et al., 1999) . Therefore, the Hh responsiveness of the boundary enhancer may be indirect and mediated by Kn. Alternatively, activation of the enhancer may require a molecular interaction between Ci and Kn. Therefore, it will be of prior interest to determine whether Kn and Ci directly regulate the boundary enhancer and cooperate for its activation. Further analysis of how the boundary enhancer integrates input from the Vg±Sd complex and Hh signalling will contribute to a molecular understanding of the synergistic activation of enhancers by signalling input and selector genes, a strategy that may be widely used to regulate gene expression during development (see also Halder et al., 1998; Mann and Affolter, 1998) .
Experimental procedures
Fly strains and genetics
Flies were grown under standard conditions. The Pelement insertion in the bs/DSRF gene has been previously described , the DE1 homozygous lethal de®ciency which includes the bs/DSRF gene (Montagne et al., 1996) was generously provided by D. Eberl and L.M. Hall, and the pointed D 88 mutant was provided by C. Kla Èmbt (Scholz et al., 1993) . Expression of BNL in all the tracheal cells was induced by crossing a UAS-bnl line with a btl-Gal4 line (Shiga et al., 1996) . Plasmid constructs were performed under standard protocols. The b -galactosidase encoded by the pHZ50pL vector is cytoplasmic (Hiromi et al., 1985) , whereas the one directed by pCb is nuclear (this vector is a generous gift from K. Basler). Transgenic¯ies were gener-ated, and the insertions were mapped genetically according to standard procedures.
Antibody and histochemical stainings
The following antibodies were used: rat anti-DSRF (Affolter et al., 1994) , rat anti-Ci (R. Holmgren), mouse and rabbit anti-b -galactosidase (Promega and Kappel, respectively), 2A12 to visualize the tracheal lumen (provided by N. Patel). Antibody stainings of embryos followed the previously described procedure (Affolter et al., 1994) . Dissection of wing imaginal discs from third instar larvae and histochemical detection of b -galactosidase were performed as described (Montagne et al., 1996) . Ectopic clones expressing Ci were induced by heat shocking¯ies carrying UAS-Ci (provided by K. Basler) and FLP-Gal4 (Pignoni and Zipursky, 1997) for 30 min at 348C during late second instar stage. Discs were dissected 48 h later and observed by confocal microscopy. Loss-of-function clones for smo were generated using the FLP-FRT method (Xu and Rubin, 1993) . smo IIG26 FRT40/CyO males also carrying an SRF reporter transgene were crossed to y hsFLP1; FRT40 p M females. Resultant larvae were heat shocked for 1.5 h at 378C before being picked as wandering third instars. Larvae were heat shocked again for 1.5 h to induce Myc expression. Larvae were dissected and stained as described (Halder et al., 1998) .
